- Home
- FTCI vs ESLA Comparison
FTCI vs ESLA Comparison
Compare FTCI & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTCI
- ESLA
- Stock Information
- Founded
- FTCI 2017
- ESLA 2021
- Country
- FTCI United States
- ESLA United States
- Employees
- FTCI N/A
- ESLA N/A
- Industry
- FTCI Semiconductors
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTCI Technology
- ESLA Health Care
- Exchange
- FTCI Nasdaq
- ESLA Nasdaq
- Market Cap
- FTCI 55.7M
- ESLA 35.5M
- IPO Year
- FTCI 2021
- ESLA N/A
- Fundamental
- Price
- FTCI $4.24
- ESLA $0.85
- Analyst Decision
- FTCI Buy
- ESLA Strong Buy
- Analyst Count
- FTCI 4
- ESLA 1
- Target Price
- FTCI $5.50
- ESLA $16.00
- AVG Volume (30 Days)
- FTCI 101.7K
- ESLA 522.0K
- Earning Date
- FTCI 08-07-2025
- ESLA 08-20-2025
- Dividend Yield
- FTCI N/A
- ESLA N/A
- EPS Growth
- FTCI N/A
- ESLA N/A
- EPS
- FTCI N/A
- ESLA N/A
- Revenue
- FTCI $55,571,000.00
- ESLA N/A
- Revenue This Year
- FTCI $102.41
- ESLA $101.09
- Revenue Next Year
- FTCI $154.53
- ESLA N/A
- P/E Ratio
- FTCI N/A
- ESLA N/A
- Revenue Growth
- FTCI N/A
- ESLA N/A
- 52 Week Low
- FTCI $1.76
- ESLA $0.63
- 52 Week High
- FTCI $7.40
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- FTCI 51.45
- ESLA 46.99
- Support Level
- FTCI $4.19
- ESLA $0.89
- Resistance Level
- FTCI $4.58
- ESLA $1.02
- Average True Range (ATR)
- FTCI 0.33
- ESLA 0.09
- MACD
- FTCI -0.04
- ESLA -0.00
- Stochastic Oscillator
- FTCI 52.21
- ESLA 21.16
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.